NU-Verap en es it fr

Categoria

NU-Verap Nombres de marca, NU-Verap Analogos

NU-Verap Marca los nombres de mezcla

  • Tarka (trandolapril + verapamil hydrochloride)
  • NU-Verap Formula quimica

    C27H38N2O4

    NU-Verap RX enlace

    http://www.rxlist.com/cgi/generic/verapsr.htm

    NU-Verap FDA hoja

    NU-Verap FDA

    NU-Verap MSDS (hoja de seguridad de materiales)

    NU-Verap Sintesis de referencia

    Dengel, EE.UU. Pat. 3,261,859 (1966)

    NU-Verap Peso molecular

    454.602 g/mol

    NU-Verap Punto de fusion

    < 25 oC

    NU-Verap H2O Solubilidad

    4,47 mg / L

    NU-Verap Estado

    Liquid

    NU-Verap LogP

    5.931

    NU-Verap Formas de dosificacion

    Cápsulas (liberación sostenida), líquido, solución, Tablet, Tablet (de liberación prolongada)

    NU-Verap Indicacion

    Para el tratamiento de la hipertensión y la angina de pecho.

    NU-Verap Farmacologia

    Verapamilo, un agente antiarrítmico de clase IV, se utiliza como calcio, bloqueadores de los canales (CCB) agente para el tratamiento de la angina, la hipertensión y las taquiarritmias supraventriculares.

    NU-Verap Absorcion

    90%

    NU-Verap Toxicidad

    LD50 = 8 mg / kg (iv en ratones)

    NU-Verap Informacion de Pacientes

    Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

    NU-Verap Organismos afectados

    Humanos y otros mamíferos